INDV Share PerformanceMore
|52 week high||382.30 17/02/17|
|52 week low||136.00 03/05/16|
|52 week change||166.60 (98.93%)|
|4 week volume||43,079,519 02/04/17|
Latest News« previous» nextMore
19/04/2017 - 14:03 StockMarketWire
Indivior has confirmed that the Company will report its financial results for Q1 2017 on 3 May. At 2:03pm: (LON:INDV) In...
19/04/2017 - 14:00 RNS
RNS Number: 5866C Indivior PLC 19 April 2017 Indivior PLC (the 'Company') Notification of First Quarter Results The Company is due to report its financial results for Q1 2017 on May 3 rd , 2017. The results will be released via Regulatory News Service, and shortly thereafter on the Company website, at 1200hrs GMT UK (0700hrs EDT in the USA). There will be a co...
07/04/2017 - 09:58 RNS
RNS Number: 9183B Indivior PLC 07 April 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Indivior PLC 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition or dispos...
28/03/2017 - 14:00 RNS
RNS Number: 7411A Indivior PLC 28 March 2017 Indivior Announces Additional Results from Clinical Studies Further Supporting the Relationship Between Sustained Plasma Levels of Buprenorphine as Delivered by RBP-6000 Monthly Depot, High Levels of -Opioid Receptor Occupancy in the Brain, and Clinical Efficacy Results also include preliminary health econ...
23/03/2017 - 14:20 StockMarketWire
Indivior has confirmed that the Annual General Meeting of the Company is scheduled to be held at 3.00pm on Wednesday...
23/03/2017 - 14:00 RNS
RNS Number: 3055A Indivior PLC 23 March 2017 Indivior PLC ('Indivior' or the 'Company') Annual Report and Accounts for the year ended December 31, 2016 ('Annual Report & Accounts 2016') and Annual General Meeting 2017 ('AGM') The Company has today posted or made available to shareholders the following documents: Annual Report & Accounts 2016; Not...
13/03/2017 - 13:00 RNS
RNS Number: 2769Z Indivior PLC 13 March 2017 Indivior PLC Announces Positive Top-line 12-Month Phase 3 Results Confirming Long-Term Safety Profile of RBP-7000 in Patients with Schizophrenia Results represent the first demonstration of safety and durability of effect for a once-monthly injectable form of subcutaneously-administered risperidone in a long-t...
13/03/2017 - 10:50 StockMarketWire
RBC Capital Markets today downgrades its investment rating on Indivior Plc (LON:INDV) to sector performer (from outp...
Latest discussion posts More
“The FT quotes: "If Indivior can navigate these legal risks while keeping market share steady, ?it could become a target for a larger peer,? RBC said in a recent note. RBC named ...”▼
“"With the fatal South Korean disinfectant scandal, tough Russian market and sluggish take-up of Scholl footwear products, LSE:RB.:Reckitt Benckiser missed City forecasts in the ...”▼
“The Telegraph's Questor again showed his form in advising to sell these at #1.70 a couple of months ago, and now they are #3.42. The RB-6000 drug had good results in its ...”▼
Codes & Symbols
|Symbols||INDV, LSE:INDV, INDV.L, INDV:LN, LON:INDV, XLON:INDV|